Chapter 10

This is a listing of all citations in this chapter.

61

Anthony Simone et al., “Acute Myocarditis Following a Third Dose of COVID-19 mRNA Vaccination in Adults,” International Journal of Cardiology, 365 (2022): 41–43, doi:10.1016/j.ijcard.2022.07.031.

62

Øystein Karlstad et al., “SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents,” Journal of American Medical Association Cardiology 7, no. 6 (2022): 600-612, doi:10.1001/jamacardio.2022.0583.

63

Martina Patone et al., “Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex,” Circulation 146, no. 10: 743-754, doi:10.1161/CIRCULATIONAHA.122.059970.

64

Hui-Lee Wong et al., “Surveillance of COVID-19 Vaccine Safety Among Elderly Persons Aged 65 Years and Older,” Vaccine 41, no. 2 (2023): 532–539, doi:10.1016/j.vaccine.2022.11.069.

65

Dror Mevorach et al., “Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel,” The New England Journal of Medicine 385, no. 23 (2021); 2140-2149, doi:10.1056/NEJMoa2109730.

66

Eric Yuk Fai Wan et al., “Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell’s Palsy: A Nested Case-Control and Self-Controlled Case Series Study,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 76, no. 3 (2023); e291–e298, doi:10.1093/cid/ciac460.

67

Kenichiro Sato et al., “Facial Nerve Palsy Following the Administration of COVID-19 mRNA Vaccines: Analysis of a Self-Reporting Database,” International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 111, (2021): 310–312, doi:10.1016/j.ijid.2021.08.071.

68

Rana Shibili et al., “Association Between Vaccination with the BNT162b2 mRNA COVID-19 Vaccine and Bell’s Palsy: A Population-Based Study,” The Lancet Regional Health. Europe 11 (2021); 100236, doi:10.1016/j.lanepe.2021.100236.

69

Erik Y.F. Wan et al., “Herpes Zoster Related Hospitalization after Inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 Vaccination: A Self-Controlled Case Series and Nested Case-Control Study,” The Lancet Regional Health: Western Pacific 21, no. 100393 (2022), doi:10.1016/j.lanwpc.2022.100393.